Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › Resources › Genomics: Clinical Implementation

Genomics: Clinical Implementation

This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests. 

Inivata Demonstrates Potential of ctDNA Assay for Cancer Recurrence, MRD Applications

Premium

In one study, the UK-based firm found that its RaDaR assay detected circulating tumor DNA in lung cancer patients up to a year before standard clinical progression occurred in most of the cases. 

Nationwide Children's Reports High Diagnostic Yield of Combined DNA, RNA Analysis in Pediatric Cancers

Comprehensive analysis by a team led by Elaine Mardis has given 93 percent of around 150 pediatric cancer patients at least one medically actionable finding.

Diversity Problem Hinders Adoption of Polygenic Risk Scores, According to ESHG Panel

Polygenic risk scores have the potential to impact cancer screening, autoimmune disease testing, and therapeutics development, but more diverse data is needed.

Cancer Experts Develop Precision Medicine-Based Genetic Testing Framework for Prostate Cancer

The framework is meant to guide healthcare providers in facilitating prostate cancer genetic testing in a timely and responsible way, the researchers said.

Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients

Two studies presented at ASCO's virtual annual meeting demonstrated the clinical utility of germline findings in guiding treatment decisions in cancer.

May 27, 2020

Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics

May 21, 2020

Q&A: ACMG Work Group Hoping to Spark Discussion on Reporting Germline Findings From Tumor Testing

May 18, 2020

Roche's Flatiron Health, Foundation Medicine, Genentech Launch Clinico-Genomic Lung Cancer Study

May 07, 2020

Burning Rock Launches 14K-Patient Trial in China to Validate Early Cancer Detection Test

Apr 30, 2020

TMB Harmonization Data Extends Concordance Findings, Tests Calibration Methods

Apr 21, 2020

ArcherDx, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers

Apr 08, 2020

Esophageal Cancer Case Study Suggests Utility as Clinicians Explore Expanded Uses for Liquid Biopsy

Premium
Apr 03, 2020

Adventist Health, CancerIQ Collaboration Identifying More Patients for Guidelines-Supported Genetic Testing

Premium
Feb 25, 2020

Epic EMR Users Begin Integrating Genomics Data for Clinical Decision Support

Premium
Feb 19, 2020

Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

Feb 06, 2020

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Jan 27, 2020

CMS to Cover FDA-Approved, -Cleared NGS Germline Tests for Breast, Ovarian Cancer Patients

Jan 13, 2020

Guardant Health to Develop Liquid Biopsy CDx for Amgen KRAS G12C Inhibitor

Jan 13, 2020

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Jan 09, 2020

Natera Launches Study for Colorectal Cancer Cell-Free DNA Blood Test

Dec 18, 2019

Ambry Genetics, Mayo Clinic Develop Mutation Prevalence Tool to Guide Docs on Appropriate Testing

Premium
Dec 13, 2019

New Data Emerges for Liquid Biopsy in Breast Cancer Residual Disease Detection

Premium
Dec 12, 2019

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Dec 09, 2019

ASH Study: Germline Testing Identifies Cancer Risk Mutations, VUS in Older AML Patients

Dec 05, 2019

Polygenic Modifiers of Pathogenic Genes May Refine Disease Risk Prediction

Premium
More articles

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.